Format

Send to

Choose Destination
J Med Chem. 2016 Apr 14;59(7):3340-52. doi: 10.1021/acs.jmedchem.6b00030. Epub 2016 Mar 23.

Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism.

Author information

1
Dipartimento di Chimica, Biologia e Biotecnologie, Università di Perugia , Via Elce di Sotto 10, 06123 Perugia, Italy.
2
Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences , 381 Royal Parade, Parkville, VIC 3052, Australia.
3
Dipartimento di Farmacia, Università di Napoli "Federico II" , Via D. Montesano 49, 80131 Napoli, Italy.
4
Dipartimento di Farmacia e Biotecnologie, Università di Bologna , Via Belmeloro 6, 40126 Bologna, Italy.
5
Dipartimento di Scienze della Vita, Università degli Studi di Siena , Via A. Moro 2, 53100 Siena, Italy.
6
Dipartimento di Neuroscienze, Area del Farmaco e Salute del Bambino (NEUROFARBA) , Viale Pieraccini 6, 50139 Firenze, Italy.
7
Dipartimento di Chimica 'G. Ciamician', Alma Mater Studiorum-Università di Bologna , Via Selmi 2, 40126 Bologna, Italy.

Abstract

We present a series of oxadiazolothiazinones, selective inotropic agents on isolated cardiac tissues, devoid of chronotropy and vasorelaxant activity. Functional and binding data for the precursor of the series (compound 1) let us hypothesize LTCC blocking activity and the existence of a recognition site specific for this scaffold. We synthesized and tested 22 new derivatives: introducing a para-methoxyphenyl at C-8 led to compound 12 (EC50 = 0.022 μM), twice as potent as its para-bromo analogue (1). For 10 analogues, we extended the characterization of the biological properties by including the assessment of metabolic stability in human liver microsomes and cytochrome P450 inhibition potential. We observed that the methoxy group led to active compounds with low metabolic stability and high CYP inhibition, whereas the protective effect of bromine resulted in enhanced metabolic stability and reduced CYP inhibition. Thus, we identified two para-bromo benzothiazino-analogues as candidates for further studies.

PMID:
26962886
DOI:
10.1021/acs.jmedchem.6b00030
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center